Leukemia, Myeloid, Acute
Showing NaN - NaN of 19
Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Oral Azacitidine
- Placebo
-
Phoenix, Arizona
- +247 more
Jan 13, 2023
Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
-
Darlinghurst, Australia
- +55 more
Dec 28, 2022
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
-
Daphne, Alabama
- +241 more
Dec 23, 2022
MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)
Completed
- Myelodysplastic Syndromes
- +2 more
-
Birmingham, Alabama
- +58 more
Aug 24, 2022
Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)
Active, not recruiting
- Leukemia, Myeloid, Acute
-
Coimbra, Portugal
- +63 more
Sep 9, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)
Active, not recruiting
- Leukemia, Myeloid, Acute
- AG-120
- +2 more
-
Duarte, California
- +72 more
Aug 18, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New Haven, Connecticut
- +23 more
Aug 1, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +94 more
Jun 9, 2022
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Marina Del Rey, California
- +35 more
Mar 11, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)
Leukemia, Myeloid, Acute Trial in Worldwide (Cytarabine, Idasanutlin, Placebo)
Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)
Completed
- Leukemia, Myeloid, Acute
- Placebo
- +2 more
-
Los Angeles, California
- +121 more
Oct 25, 2021
Survival in Patients Older Than 60 Years With Newly Diagnosed
Completed
- Leukemia, Myeloid, Acute
-
Jerez, Andalucía/Cádiz, Spain
- +39 more
May 20, 2021
Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- Azacitidine
- +3 more
-
Alcalá De Henares, Spain
- +14 more
May 17, 2021
Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)
Completed
- Leukemia, Myeloid, Acute
- SGI-110 (guadecitabine)
- Treatment Choice
-
Scottsdale, Arizona
- +134 more
Dec 21, 2020
Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine 20 mg/m^2, Talacotuzumab 9 mg/kg)
Completed
- Leukemia, Myeloid, Acute
- Decitabine 20 mg/m^2
- Talacotuzumab 9 mg/kg
-
Orange, California
- +80 more
Mar 11, 2019